Tuesday, July 29, 2003
United States Patent and Trademark Office
Arlington, Virginia 22202
Patent Academy, Crystal Square 4, 7th Floor
The most recent quarterly meeting for the Biotechnology and Chemical Pharmaceutical Customer Partnership was held on April 29, 2003, at the U.S. Patent and Trademark Office. The Biotechnology and Chemical Pharmaceutical Customer Partnership is designed and developed to be a forum to share ideas, experiences, and insights between individual users and the USPTO. The USPTO does not intend to use these customer partnership groups to arrive at any consensus. Invitations to participate will indicate that individual opinions are sought, rather than a group consensus and that the meetings are intended to be informal in nature and have varying participants. These customer partnership groups are formed with full recognition of the USPTO's responsibility under the Federal Advisory Committee Act (FACA), and that these customer partnership groups are not established as FACA compliant committees.
We value our customers in obtaining feedback from individual participants is important in our efforts to continuously improve the quality of our products and services. Your willing participation is helpful in providing us with insights and experiences in this informal process to assist us.
The next meeting of the US Patent and Trademark Office Biotechnology and Chemical Pharmaceutical Customer Partnership is scheduled for Tuesday , July 29, 2003 from 9:00 am to 4:30pm, Patent Academy, Crystal Square 4, 7th Floor, located on 1745 Jefferson Davis Highway, Arlington, Virginia.
Please contact Cecilia Tsang at 703-308-0254 or by fax at 703-746-7144 or email Cecilia.Tsang@uspto.gov or contact Sharlamar Taliaferro at 703-306-4094 or by fax 703-305-8002 or email Sharlamar.Taliaferro@uspto.gov to decline or confirm your attendance.
|9:00 - 9:15 AM||Greetings and Overview||Jasemine Chambers John Doll|
Directors, TC 1600
|9:15 - 10:15 AM|
New Rules Package
|10:15 - 10:30 AM||Break|
|10:30 - 11:15 AM||Examiner Enablement Training||Robert Hill|
|11:15 - 11:45 AM||Examiner Practice under|
In re Baird/In re Ochiai
|James Wilson, SPE|
|1:00 - 1:45 PM||Reach-Through Claims||(TBA-Page/Richter/Elliott)|
|1:45 - 2:30 PM||% Homology Claims||Brian Stanton, QAS TC 1600|
|1:45 - 2:30 PM||Break|
|2:45 - 3:15 PM||EFS/Pair||SIRA|
|3:15 - 3:45 PM||Unity Study Overview||Bruce Kisliuk, Director TC 1600|
|3:45 - 4:00 PM||Closing Remarks||Jasemine Chambers John Doll|
Directors, TC 1600